Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Vassal

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
Has chemotherapy reached its limits in pediatric cancers?Gilles Vassal
European Journal of Cancer (Oxford, England : 1990)|May 8, 2009
Will children with cancer benefit from the new European Paediatric Medicines Regulation?Gilles Vassal
International Journal of Pharmaceutics|August 14, 2012
Off-patent oral oncology drugs for kids (O3K FP7-project): from bedside to PUMAAngelo Paci, Gilles Vassal
The Lancet. Oncology|November 2, 2013
Need for change in implementation of paediatric regulationGilles Vassal, Patricia Blanc, Andy Pearson
The Lancet. Oncology|November 18, 2022
Cancer research in Europe: a focus on children and young peopleGilles Vassal, Andrew D J Pearson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Population pharmacokinetics of busulfan in children--letterLaurent Nguyen, Angelo Paci, Gilles Vassal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2013
Is the European pediatric medicine regulation working for children and adolescents with cancer?Gilles Vassal, Birgit Geoerger, Bruce Morland
Expert Review of Anticancer Therapy|May 13, 2008
AKT pathway in neuroblastoma and its therapeutic implicationHervé Sartelet, Luc-Laurier Oligny, Gilles Vassal
Therapie|December 6, 2003
Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agentsGilles Vassal, Dominique Méry-Mignard, Charles Caulin
The Lancet. Oncology|October 14, 2016
Access to loan-related insurance for French cancer survivorsAgnès Dumas, Florent De Vathaire, Gilles Vassal
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
Has chemotherapy reached its limits in pediatric cancers?Gilles Vassal
European Journal of Cancer (Oxford, England : 1990)|May 8, 2009
Will children with cancer benefit from the new European Paediatric Medicines Regulation?Gilles Vassal
International Journal of Pharmaceutics|August 14, 2012
Off-patent oral oncology drugs for kids (O3K FP7-project): from bedside to PUMAAngelo Paci, Gilles Vassal
The Lancet. Oncology|November 2, 2013
Need for change in implementation of paediatric regulationGilles Vassal, Patricia Blanc, Andy Pearson
The Lancet. Oncology|November 18, 2022
Cancer research in Europe: a focus on children and young peopleGilles Vassal, Andrew D J Pearson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Population pharmacokinetics of busulfan in children--letterLaurent Nguyen, Angelo Paci, Gilles Vassal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2013
Is the European pediatric medicine regulation working for children and adolescents with cancer?Gilles Vassal, Birgit Geoerger, Bruce Morland
Expert Review of Anticancer Therapy|May 13, 2008
AKT pathway in neuroblastoma and its therapeutic implicationHervé Sartelet, Luc-Laurier Oligny, Gilles Vassal
Therapie|December 6, 2003
Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agentsGilles Vassal, Dominique Méry-Mignard, Charles Caulin
The Lancet. Oncology|October 14, 2016
Access to loan-related insurance for French cancer survivorsAgnès Dumas, Florent De Vathaire, Gilles Vassal
Pageof 26